Published On: Sat, May 29th, 2021

Zydus Cadila gets FDA approval for Fluphenazine Hydrochloride Tablets

Tagged with: | | | | | |

(also known as Zydus Cadila) said that it has secured final approval from the (FDA) to market Fluphenazine Hydrochloride Tablets 1 mg, 2.5 mg, 5 mg, and 10 mg.

The reference listed drug (RLD) of Zydus Cadila’ Fluphenazine Hydrochloride Tablets is , which are indicated for the treatment of symptoms of a certain type of mental/mood condition (schizophrenia).

Zydus Cadila said that Fluphenazine comes under a class of medications called phenothiazines and is also referred to as a neuroleptic.

The Indian pharma company plans to manufacture Fluphenazine Hydrochloride Tablets at its formulation manufacturing facility in Ahmedabad.

Zydus Cadila gets FDA approval for Fluphenazine Hydrochloride Tablets

Zydus Cadila gets FDA approval for Fluphenazine Hydrochloride Tablets. Photo courtesy of The U.S. /Wikipedia.org.

Zydus Cadila boasts 318 drug approvals and has filed more than 400 abbreviated new drug applications (ANDAs) to date since the start of the filing process in FY 2003-04.

Earlier this week, the company signed a license supply and commercialization deal with Taiwanese pharmaceutical company to commercialize the latter’s AmphoTLC (Amphotericin B Liposome for Injection 50mg) for the treatment of Black Fungus in India.

Related posts

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Recent Posts